SCHEMBL28863115

SCHEMBL28863115

CO/N=C/c1c(C)cccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 1/20 0.44
▸ ATM Q13315 3/20 0.42
▸ TRPA1 O75762 2/20 0.42
▸ ALDH1A1 P00352 5/20 0.39
▸ MAPT P10636 5/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ POLB P06746 3/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ MPI P34949 2/20 0.39
▸ RECQL P46063 1/20 0.39
▸ TTR P02766 1/20 0.39
▸ RET P07949 1/20 0.35
▸ LMNA P02545 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ ALOX15 P16050 2/20 0.35
▸ ALOX12 P18054 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14396721 0.88 SRC (0.50) SRCTRPA1ALDH1A1MAPTKDM4E
SCHEMBL31747007 0.79 ATM (0.46) ATMTRPA1ALDH1A1MAPTKDM4E
SCHEMBL27108052 0.79 ATM (0.46) ATMTRPA1ALDH1A1MAPTKDM4E
SCHEMBL13550677 0.79 ATM (0.46) ATMTRPA1ALDH1A1MAPTKDM4E
SCHEMBL19880486 0.78 NPSR1 (0.49) SRCALDH1A1MAPTKDM4EPOLB
SCHEMBL21883711 0.78 ACHE (0.40) SRCALDH1A1MAPTPOLBRECQL
SCHEMBL19594037 0.78 ALDH1A1 (0.40) SRCALDH1A1MAPTRETGAA
SCHEMBL19880559 0.74 TSHR (0.46) SRCALDH1A1MAPTKDM4EPOLB
SCHEMBL6073256 0.72 POLB (0.62) SRCALDH1A1MAPTKDM4EPOLB
SCHEMBL10903092 0.71 SRC (0.46) SRCALDH1A1MAPTKDM4ERET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108473408-A Ascochlorin derivative and its purposes as AMPK activator NRL制药股份有限公司 2018-08-31 — — CN disclosed
Send feedback